Medtech Talk

CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E

03.06.2018 - By HealthegyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

John H. Stevens, MD, was too excited to sleep when he first heard what HeartFlow's technology could potentially do. Eight years later, he's sleeping a lot better, having secured $240 million to fund the company's commercial rollout of the HeartFlow Analysis system.Overview: HeartFlow has built a strong financial argument for its imaging system.Surprises: This stuff belongs on Star Trek. Very cool.Takeaway: "There are no shortcuts."

More episodes from Medtech Talk